Evidence map›Paper›PMID 25871972›Full record

ArticleTranslational psychiatry2015

No evidence for attenuated stress-induced extrastriatal dopamine signaling in psychotic disorder.

D Hernaus, D Collip, Z Kasanova, O Winz, A Heinzel, T van Amelsvoort, S M Shali, J Booij, Y Rong, M Piel and 3 more

Abstract read
In one paragraph

Article in Translational psychiatry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Dopamine and glutamate in schizophrenia: biology, symptoms and treatment.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2020
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

D HernausDepartment of Psychiatry and Psychology, South Limburg Mental Health Research and Teaching Network, EURON, School for Mental Health and NeuroScience MHeNS Maastricht University, Maastricht, The Netherlands.
D CollipDepartment of Psychiatry and Psychology, South Limburg Mental Health Research and Teaching Network, EURON, School for Mental Health and NeuroScience MHeNS Maastricht University, Maastricht, The Netherlands.
Z KasanovaDepartment of Psychiatry and Psychology, South Limburg Mental Health Research and Teaching Network, EURON, School for Mental Health and NeuroScience MHeNS Maastricht University, Maastricht, The Netherlands.
O WinzDepartment of Nuclear Medicine, University Hospital RWTH Aachen University, Aachen, Germany.
A HeinzelDepartment of Nuclear Medicine, University Hospital RWTH Aachen University, Aachen, Germany.
T van Amelsvoort1] Department of Psychiatry and Psychology, South Limburg Mental Health Research and Teaching Network, EURON, School for Mental Health and NeuroScience MHeNS Maastricht University, Maastricht, The Netherlands [2] Department of Nuclear Medicine, Academic Medical Center, Amsterdam, The Netherlands.
S M ShaliDepartment of Nuclear Medicine, University Hospital RWTH Aachen University, Aachen, Germany.
J BooijDepartment of Nuclear Medicine, Academic Medical Center, Amsterdam, The Netherlands.
Y RongDepartment of Nuclear Medicine, University Hospital RWTH Aachen University, Aachen, Germany.
M PielInstitute of Nuclear Chemistry, Johannes Gutenberg University, Mainz, Germany.
J PruessnerDepartment of Psychiatry, Douglas Mental Health Institute, McGill University, Montreal, QC, Canada.
F M Mottaghy1] Department of Nuclear Medicine, University Hospital RWTH Aachen University, Aachen, Germany [2] Department of Nuclear Medicine, Maastricht University Hospital, Maastricht, The Netherlands.
I Myin-GermeysDepartment of Psychiatry and Psychology, South Limburg Mental Health Research and Teaching Network, EURON, School for Mental Health and NeuroScience MHeNS Maastricht University, Maastricht, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stress is an important risk factor in the etiology of psychotic disorder. Preclinical work has shown that stress primarily increases dopamine (DA) transmission in the frontal cortex. Given that DA-mediated hypofrontality is hypothesized to be a cardinal feature of psychotic disorder, stress-related extrastriatal DA release may be altered in psychotic disorder. Here we quantified for the first time stress-induced extrastriatal DA release and the spatial extent of extrastriatal DA release in individuals with non-affective psychotic disorder (NAPD). Twelve healthy volunteers (HV) and 12 matched drug-free NAPD patients underwent a single infusion [(18)F]fallypride positron emission tomography scan during which they completed the control and stress condition of the Montreal Imaging Stress Task. HV and NAPD did not differ in stress-induced [(18)F]fallypride displacement and the spatial extent of stress-induced [(18)F]fallypride displacement in medial prefrontal cortex (mPFC) and temporal cortex (TC). In the whole sample, the spatial extent of stress-induced radioligand displacement in right ventro-mPFC, but not dorso-mPFC or TC, was positively associated with task-induced subjective stress. Psychotic symptoms during the scan or negative, positive and general subscales of the Positive and Negative Syndrome Scale were not associated with stress-induced [(18)F]fallypride displacement nor the spatial extent of stress-induced [(18)F]fallypride displacement in NAPD. Our results do not offer evidence for altered stress-induced extrastriatal DA signaling in NAPD, nor altered functional relevance. The implications of these findings for the role of the DA system in NAPD and stress processing are discussed.

Indexed as

AdultBenzamidesBrainCase-Control StudiesDopamineFemaleFluorine RadioisotopesHumansMaleMiddle AgedNeostriatumPositron-Emission TomographyPrefrontal CortexPsychotic DisordersStress, PsychologicalSynaptic TransmissionBenzamidesDopaminefallyprideFluorine Radioisotopes

Identifiers

PMID25871972
PMCPMC4462602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.